Ran Nussbaum

Affiliations

  • Director at Urogen Pharma Ltd. (URGN), 2021-06-09
  • Large Shareholder, Director at Keros Therapeutics Inc. (KROS), 2021-06-03
  • at Eloxx Pharmaceuticals Inc. (ELOX), 2021-05-20
  • Director at Prevail Therapeutics Inc. (PRVL), 2021-01-26
  • Director at Arqule Inc (ARQL), 2020-01-16
  • Director at Vbi Vaccines Inc (VBIV), 2017-11-01
  • Director at Kite Pharma Inc. (KITE), 2017-10-06
  • Large Shareholder at Arno Therapeutics Inc (ARNI), 2016-09-08
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ELOX $1.35 592,592 Director 616,592 2021-05-13 Filing
ELOX $1.35 1,422,222 Director 1,989,551 2021-05-13 Filing
ELOX $1.35 2,630,487 Director 3,679,797 2021-05-13 Filing
ELOX $1.35 1,280,624 Director 1,791,470 2021-05-13 Filing
KROS $50.00 6,000 Large Shareholder, Director 155,262 2020-11-17 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
KITE $56.08 24,070 Director 0 2015-06-02 Filing
KITE $55.27 200,604 Director 24,070 2015-06-02 Filing
KITE $57.38 7,800 Director 224,674 2015-06-01 Filing
KITE $56.44 3,754 Director 232,474 2015-06-01 Filing
KITE $55.05 69,206 Director 236,228 2015-06-01 Filing